Valuation : Avinger, Inc.

Market Cap 27.07L 23.33L 21.87L 19.97L 37.61L 26Cr 37.73L 2.59Cr 1.01Cr 13Cr 1.02Cr 99.43L 43Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.11Cr 1.04Cr 94.6L 1.78Cr 122.59Cr 1.79Cr 12Cr 4.8Cr 62Cr 4.82Cr 4.71Cr 205.2Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
14
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
6,18,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Date Insider Type Main position Quantity % Market Cap.
23/01/25 Sell

Founder

2,215 0.0669%
23/01/25 Sell

Chief Financial Officer

1,255 0.0379%
23/01/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-93.13% 15.15L
+0.27%-0.42%-22.53%+2.50% 1.28TCr
-3.83%-6.27%+14.51%+4.47% 440.53Cr
-0.20%-5.65%-40.42%-55.80% 123.26Cr
+1.00%-0.63%-36.83%-36.76% 115.78Cr
+0.08%-0.89%+19.24%+86.69% 111.34Cr
-1.14%-1.20%-37.77% - 104.66Cr
-2.47%+8.21% - - 103.5Cr
+0.95%-3.68%+33.66%+124.70% 54Cr
-2.15%-1.50%+50.89% - 30Cr
Average -2.82%+2.73%-2.14%+4.67% 236.5Cr
Weighted average by Cap. -0.69%+0.06%-13.37%+4.87%

Financials

2022 2023
Net sales 82.73L 71.29L 66.84L 61.02L 1.15Cr 79Cr 1.15Cr 7.93Cr 3.09Cr 40Cr 3.11Cr 3.04Cr 132.35Cr 76.52L 65.94L 61.82L 56.44L 1.06Cr 73Cr 1.07Cr 7.33Cr 2.86Cr 37Cr 2.87Cr 2.81Cr 122.41Cr
Net income -1.76Cr -1.52Cr -1.42Cr -1.3Cr -2.45Cr -168.43Cr -2.46Cr -17Cr -6.59Cr -85Cr -6.62Cr -6.47Cr -281.92Cr -1.83Cr -1.58Cr -1.48Cr -1.35Cr -2.55Cr -175.09Cr -2.55Cr -18Cr -6.85Cr -88Cr -6.88Cr -6.73Cr -293.07Cr
Net Debt 17.56L 15.13L 14.19L 12.95L 24.4L 17Cr 24.48L 1.68Cr 65.67L 8.47Cr 65.93L 64.49L 28Cr 1.01Cr 87.2L 81.76L 74.64L 1.41Cr 97Cr 1.41Cr 9.7Cr 3.78Cr 49Cr 3.8Cr 3.72Cr 161.89Cr
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock